Justin Zamirowski Better Therapeutics, Inc. (BTTX) insider trading activity

BTTX Quotes by TradingView

Justin Zamirowski is Chief Commercial Officer of Better Therapeutics, Inc.. Currently has a direct ownership of 36,913 shares of BTTX, which is worth approximately $369. The most recent transaction as insider was on May 27, 2022, when has been sold 1,677 shares (Common Stock) at a price of $0.5 per share, resulting in proceeds of $838. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.9K
0% 3M change
0% 12M change
Total Value Held $369

Justin Zamirowski Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 27 2022
BUY
Exercise of conversion of derivative security
$838 $0.5 p/Share
1,677 Added 4.35%
36,913 Common Stock
May 16 2022
BUY
Exercise of conversion of derivative security
$17,618 $0.5 p/Share
35,236 Added 50.0%
35,236 Common Stock
JZ

Justin Zamirowski

Chief Commercial Officer
San Francisco, CA

Track Institutional and Insider Activities on BTTX

Follow Better Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BTTX shares.

Notify only if

Insider Trading

Get notified when an Better Therapeutics, Inc. insider buys or sells BTTX shares.

Notify only if

News

Receive news related to Better Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BTTX